CNTG

Centogene N.V.

0.37 USD
-0.00 (-0.83%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Centogene N.V. stock is down -24.31% since 30 days ago. The next earnings date is Sep 5, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 20% of the previous 4 May’s closed higher than April.

About Centogene N.V.

Centogene N.V. focuses on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing. The company develops rare disease platform, which includes epidemiologic, phenotypic, and heterogenetic data that enhances methods for identifying and monitoring rare hereditary diseases.